IMM2902 inhibits tumor cell growth by speeding up the endocytosis and degradation of HER2 and enhances the phagocytosis of macrophages against tumor cells by blocking the interaction between CD47 and SIRPα, which acts as a “don’t eat me” signal [84]. Here, SIRPA is linked to neoplasm.